[Tree] Senate panel approves CJS FY25 spending bill with science and tech boosts
Version 0.08 (2024-07-29 20:02:18.410000)
updates: The U.S. Senate Appropriations Committee approves the CJS FY25 spending bill with increased funding for science and technology programs
- ➔
Version 0.07 (2024-07-11 00:55:47.592000)
updates: The Senate bill aims to enhance the intelligence community's technological capabilities through partnerships with the private sector. A companion measure in the House, the EPIC Act, aims to support critical scientific and technical initiatives at the National Institute of Standards and Technology (NIST) by creating a nonprofit Foundation for Standards and Metrology. The EPIC Act would enable NIST to collaborate more closely with the private sector, nonprofits, and academia, and mobilize private and philanthropic funding to support NIST's initiatives.
- ➔
- ➔
- ➔
Version 0.06 (2024-07-10 19:58:50.748000)
updates: The story now includes information about the companion measure in the House that aims to enhance technological initiatives at NIST
- ➔
- ➔
Version 0.05 (2024-05-27 09:15:54.348000)
updates: US Senate bill aims to enhance intelligence community's technological capabilities
- ➔
Version 0.04 (2024-01-15 23:18:47.340000)
updates: The U.S. National Security Commission on Emerging Biotechnology has released its initial report, outlining findings and recommendations for policymakers. The report emphasizes the promise of biotechnology for national security and economic competitiveness. Legislative recommendations for congressional action in the Farm Bill reauthorization have been made. The Commission aims to drive policies and practices that leverage American biotechnology to bolster national security.
- ➔
- ➔
- ➔
- ➔
Version 0.02 (2024-01-12 23:16:31.203000)
updates: Interim report released by bipartisan commission on biotechnology and national security
- ➔
- ➔
Version 0.01 (2024-01-12 17:15:44.575000)
updates: Includes the announcement of the findings and recommendations of the bipartisan National Biotech Commission's first public report
- ➔